Evidence map›Paper›PMID 30462637›Full record

ArticlePLoS neglected tropical diseases2018

Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys.

Dima A Hammoud, Margaret R Lentz, Abigail Lara, Jordan K Bohannon, Irwin Feuerstein, Louis Huzella, Peter B Jahrling, Matthew Lackemeyer, Joseph Laux, Oscar Rojas and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Cytometry in High-Containment Laboratories.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Dima A HammoudCenter for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland, United States of America.
Margaret R LentzNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Abigail LaraNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Jordan K BohannonNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Irwin FeuersteinNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Louis HuzellaNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Peter B JahrlingNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Matthew LackemeyerNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Joseph LauxNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Oscar RojasNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Philip SayreNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.ORCID 0000-0002-2256-4056
Jeffrey SolomonClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Ft. Detrick, Frederick, MD, United States of America.
Yu CongNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.
Vincent MunsterVirus Ecology Unit, Laboratory of Virology, Rocky Mountain Laboratories, Hamilton, MT, United States of America.
Michael R HolbrookNIAID Integrated Research Facility, Ft. Detrick, Frederick, MD, United States of America.ORCID 0000-0002-0824-2667
Frederick National Laboratory for Cancer Research · USNational Institutes of Health Clinical Center · US

Funding

Virus Ecology UnitZIAAI001179 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MUNSTER, VINCENT · 2013 to 2025
$24.3M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS HHSN272200700016INIH HHS HHSN272200700016I
6 · The paper itself

Abstract

Nipah virus (NiV) infection can lead to severe respiratory or neurological disease in humans. Transmission of NiV has been shown to occur through contact with virus contaminated fomites or consumption of contaminated food. Previous results using the African green monkey (AGM) model of NiV infection identified aspects of infection that, while similar to humans, don't fully recapitulate disease. Previous studies also demonstrate near uniform lethality that is not consistent with human NiV infection. In these studies, aerosol exposure using an intermediate particle size (7μm) was used to mimic potential human exposure by facilitating virus deposition in the upper respiratory tract. Computed tomography evaluation found some animals developed pulmonary parenchymal disease including consolidations, ground-glass opacities, and reactive adenopathy. Despite the lack of neurological signs, magnetic resonance imaging identified distinct brain lesions in three animals, similar to those previously reported in NiV-infected patients. Immunological characterization of tissues collected at necropsy suggested a local pulmonary inflammatory response with increased levels of macrophages in the lung, but a limited neurologic response. These data provide the first clear evidence of neurological involvement in the AGM that recapitulates human disease. With the development of a disease model that is more representative of human disease, these data suggest that NiV infection in the AGM may be appropriate for evaluating therapeutic countermeasures directed at virus-induced neuropathogenesis.

Indexed as

AerosolsAnimalsChlorocebus aethiopsCytokinesDisease Models, AnimalFemaleHenipavirus InfectionsHumansLungMaleNervous System DiseasesNipah VirusParticle SizeRespiratory Tract InfectionsAerosolsCytokines

Identifiers

PMID30462637
PMCPMC6281276
OpenAlexW2900525060

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.